Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation.
about
Fas-activated serine/threonine kinase (FAST K) synergizes with TIA-1/TIAR proteins to regulate Fas alternative splicingSF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activationCo-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndromeSoluble Fas (APO-1/CD95) isoform in adult T-cell leukemia.Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetranceFrequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma.Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative Splicing.Consequences of regulated pre-mRNA splicing in the immune system.Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation.Control of alternative splicing in immune responses: many regulators, many predictions, much still to learnIn Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide MetforminStructural basis for the recognition of spliceosomal SmN/B/B' proteins by the RBM5 OCRE domain in splicing regulationIdentification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor.A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras.Identification of cells deficient in signaling-induced alternative splicing by use of somatic cell genetics.Polymorphisms of extrinsic death receptor apoptotic genes (FAS -670 G>A, FASL -844 T>C) in coronary artery disease.A membrane-bound Fas decoy receptor expressed by human thymocytes.Strict 3' splice site sequence requirements for U2 snRNP recruitment after U2AF binding underlie a genetic defect leading to autoimmune disease.Serum levels of soluble fas in patients with multinodular goiter.Soluble Fas gene therapy protects against Fas-mediated apoptosis of hepatocytes but not the lethal effects of Fas-induced TNF-alpha production by Kupffer cells.Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma.Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes.Oligomerization of soluble Fas antigen induces its cytotoxicity.Inverted ratio of m-fas/s-fas expression in early onset pauciarticular juvenile chronic arthritis
P2860
Q24321295-9072035B-3D8E-48B1-A16D-3CBE8FBF2244Q28139602-BB486BB8-452E-4251-954E-B45A7E0A2165Q30838565-0A5343C4-C15C-44C8-BF25-E833A8B663BAQ34244551-48D58345-F6F5-4733-89D2-290C0E8DEEDCQ34389314-D06D3384-EEDB-4F23-A59F-C56261C30660Q35748214-FD2DE86C-71A9-4BF9-9686-8D22369820EAQ35805025-A38889CE-43CD-429D-9F98-6D5C4912A365Q35968460-11415F11-C88E-4A46-B468-FCC9424DC716Q36622253-4CC114A3-8709-4A4A-8EBE-396E8818290BQ36751866-E014377F-D274-44AA-A58C-C79ACEB9E620Q36928108-CDBB222C-A6F4-4B04-A9A3-CBD7A52A410BQ37452098-5D0F974C-6E82-4B1C-9B15-B5673EBB4B3BQ38317125-E41881D1-C0BA-4FD8-B2EC-F58BEC2F8DADQ39450030-3D6C86F4-C546-4C8A-84BF-367EC243246EQ40679291-E79A33D8-65C5-45E3-980F-F7B907BD66CCQ40883676-55899A85-3D08-4285-A493-7B0800011D1EQ41724440-FC831673-4C94-4074-8C4D-1491B376F21AQ41896179-DD3A6514-8555-4DFE-9ABB-C8973EB54902Q43265538-5B7A7A9D-4CAE-423E-A282-672F11D27C3EQ45886341-161CC01A-3203-49CB-801E-1207D3F66EC4Q47901999-3073EA25-9B51-49F2-9652-90415A3F0D3AQ53379253-B5A68643-51AE-40BD-BD54-7EF8BB400AEDQ54764961-9F34E300-404B-485C-BCDB-F7B7C6B59E4AQ57956202-F93393A6-5B9D-4759-A92E-00EAF3334E86
P2860
Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Differential expression of hum ...... d mononuclear cell activation.
@en
type
label
Differential expression of hum ...... d mononuclear cell activation.
@en
prefLabel
Differential expression of hum ...... d mononuclear cell activation.
@en
P2093
P2860
P356
P1433
P1476
Differential expression of hum ...... d mononuclear cell activation.
@en
P2093
P2860
P304
P356
10.1042/BJ3100957
P407
P478
310 ( Pt 3)
P577
1995-09-01T00:00:00Z